Stem Cell Therapy-Facet Syndrome Back Pain: Alternatives To Back Surgery
How to know if the cause of your back pain or neck pain is Facet Syndrome. Discover how biologic regenerative treatments are able to pick up where traditiona...
By: StemCell ARTS
Read the original:
Stem Cell Therapy-Facet Syndrome Back Pain: Alternatives To Back Surgery - Video
Failure to legislate will hurt research
Tuesday, January 28, 2014
Even though stem cell manufacture has just been licensed in this country, the Governments ongoing failure to legislate in this area means pharmaceutical giants will still be wary of investing here, according to an expert in stem cell therapy.
CCMI General Manager Andrew Finnerty, CCMI Director Tim O'Brien, Minister Sean Sherlock and President of NUI Galway Dr. James Browne. Photograph by Aengus McMahon
Once the stem cells are harvested from the bone marrow of adult donors, they are grown in the Galway laboratory to generate sufficient quantities.
The first clinical trial using these stem cells is being funded by the Health Research Board and Science Foundation Ireland and will investigate the safety of using mesenchymal stem cells (MSCs) isolated from bone marrow for the treatment of critical limb ischemia, a complication associated with diabetes which can lead to limb amputation.
John ODea of the Irish Medical Devices Association (IMDA) said the centre was a key step.
I look forward to seeing its continued growth to assist in developing the skill sets and techniques that will be needed to embrace the new manufacturing opportunities that this exciting area will bring, he said.
The centre, one of a handful in Europe authorised for stem cell manufacture, has been developed by researchers at NUIGs regenerative medicine institute.
However, Dr Stephen Sullivan, chief scientific officer with the Irish Stem Cell Foundation warned all stem cell research operates at a pan-global level driven by big pharma and international equity firms and these players will only engage with researchers in countries where there is solid stem cell legislation in place. He welcomed the centre as a first step but said if Ireland is to compete at a top international standard, legislation remains necessary.
Read the original:
Failure to legislate ‘will hurt research’
January 28, 2014
Ranjini Raghunath for redOrbit.com Your Universe Online
Cancer treatment through chemotherapy, radiation or stem cell therapies can be physically and mentally exhausting for patients, especially younger ones. Many factors can help them feel positive about themselves and their treatment, including spiritual practices, supportive home environments and strong social connections with friends, family and physicians.
Now, a new study shows that making music videos and writing song lyrics may also help young cancer patients better cope with their treatment.
Researchers at the Indiana University School of Nursing, Indianapolis, carried out the music therapy intervention study, which was published online in the journal Cancer.
113 young patients aged 11-24 undergoing stem cell transplants for cancer were selected randomly for the study. Half of them were given audiobooks (the control group) and the other half were given three weeks to write down song lyrics, collect images and record music videos.
Patients in the second (test) group went through six training sessions each with a music therapist, who helped them identify and write about what was important to them, and guided them in creating the videos.
It really targeted them writing, having an opportunity to write about whats important to them, co-author of the study and music therapist, Sheri Robb, told Reuters. A lot of these kids as theyre going through treatment, they tend to not talk about these things.
The patients also had a chance to share the videos they created with family and friends. After about 100 days of treatment, patients in the test group reported that making those videos helped them better connect with their loved ones.
The intervention therapy helped the young patients feel stronger, more positive and helped improve their relationships with family and physicians, based on their responses to follow-up questionnaires, the researchers reported.
Follow this link:
Making Music Videos Helps Young Cancer Patients Cope With Treatment
Q&A - Stem cells could offer treatment for a myriad of diseases
Tuesday, January 28, 2014
Q.What are stem cells?
Stem cells are different however as they are at an earlier stage in cell development and this means they can make more cells and transform into different cell types such as a skin stem cell can make all the different types of skin cells.
Q. And there are two types? A.Yes. There are two types of stem cells: embryonic stem cells and adult stem cells. Embryonic stem cells can generate all cells of the human body. Adult stem calls generate a more limited number of human cell types.
Q.Why are stem cells so important? A.For many years, adult stem cells have been used to treat rare blood and certain cancers.
However, adult stem cells cant generate all cell types. For example, scientists say there doesnt appear to be an adult stem cell that can make insulin- secreting cells of the pancreas. Embryonic stem cells can, however, as they can generate all cell types and the aim of scientists is to use these embryonic cells to generate healthy tissue to replace cells compromised by disease. This means that embryonic cells are more scientifically useful.
Q. And its also embryonic cells that are the more controversial, right? A.The use of embryonic stem cells is controversial here and in other countries as certain groups believe it is morally wrong to experiment on an embryo that could become a human. Embryonic stem cells are taken from embryos left over after assisted fertility treatments. According to the Irish Stem Cell Foundation, if they werent used for research into human disease, they would be discarded as medical waste. Embryos are not created purely for research purposes they say.
Q. Why are they so useful? A. Among the conditions which scientists believe may eventually be treated by stem cell therapy are Parkinsons disease, Alzheimers disease, heart disease, stroke, arthritis, diabetes, burns and spinal cord damage. Early trials are under way for treating forms of blindness. It is also hoped we can learn from embryonic stem cells how early body tissues develops and more about the pathway of diseases. This will enable us to make better and more effective drugs.
Irish Examiner Ltd. All rights reserved
Continue reading here:
Q&A - Stem cells could offer treatment for a myriad of diseases
27/01/2014 - 09:35:51Back to Ireland Home
Stem cells for human use are to be made in a university lab in the first medical programme of its kind in Ireland.
Scientists behind the new facility at the National University of Ireland Galway will aim to produce adult cells to combat conditions like arthritis, heart disease and diabetes.
Stem cells created at the lab will be used in clinical trials following regulatory approval the first of which is to test their effects on critical limb ischemia, a common complication associated with diabetes which often results in amputation.
The cells, mesenchymal stem cells (MSCs), will undergo safety tests after being isolated from bone marrow from donors and grown in the laboratory to generate sufficient quantities.
The university said it will position it as a global player in regenerative medicine.
NUI Galways Centre for Cell Manufacturing Ireland is the first facility on the island of Ireland to receive a licence from the Irish Medicines Board to manufacture culture-expanded stem cells for human use.
And it is one of less than half a dozen in Europe authorised for the process.
President of NUI Galway Dr Jim Browne said: Developing Galways role as med-tech hub of global standing, the Centre for Cell Manufacturing Ireland captures NUI Galways commitment to bring bold ideas to life.
Innovation can bridge the gap between patient and provider and meet the needs of industry and the wider society in a balanced way.
Continued here:
Galway stem cell lab to be used in fight against heart disease and diabetes
Stem cells for human use are to be made in a university lab in the first medical program of its kind in Ireland.
Scientists behind the new facility at the National University of Ireland (NUI) Galway will aim to produce adult cells to combat conditions like arthritis, heart disease and diabetes.
Stem cells created at the lab will be used in clinical trials following regulatory approval - the first of which is to test their effects on critical limb ischemia, a common complication associated with diabetes which often results in amputation.
The cells, mesenchymal stem cells (MSCs), will undergo safety tests after being isolated from bone marrow from donors and grown in the laboratory to generate sufficient quantities.
The university said it will position it as a global player in regenerative medicine.
NUI Galway's Centre for Cell Manufacturing Ireland is the first facility in Ireland to receive a licence from the Irish Medicines Board to manufacture culture-expanded stem cells for human use.
And it is one of less than half a dozen in Europe authorised for the process.
'Developing Galway's role as med-tech hub of global standing, the Centre for Cell Manufacturing Ireland captures NUI Galway's commitment to bring bold ideas to life,' said NUI Galway president Dr Jim Browne.
'Innovation can bridge the gap between patient and provider and meet the needs of industry and the wider society in a balanced way.'
Stem cells are best described as serving as the body's repair mechanism and in recent years science has isolated them from tissues such as bone marrow and fat to recreate them in laboratory settings.
Read the rest here:
Ireland uni lab in stem cells move
Stem cells for human use are to be made in a university lab in the first medical program of its kind in Ireland.
Scientists behind the new facility at the National University of Ireland (NUI) Galway will aim to produce adult cells to combat conditions like arthritis, heart disease and diabetes.
Stem cells created at the lab will be used in clinical trials following regulatory approval - the first of which is to test their effects on critical limb ischemia, a common complication associated with diabetes which often results in amputation.
The cells, mesenchymal stem cells (MSCs), will undergo safety tests after being isolated from bone marrow from donors and grown in the laboratory to generate sufficient quantities.
The university said it will position it as a global player in regenerative medicine.
NUI Galway's Centre for Cell Manufacturing Ireland is the first facility in Ireland to receive a licence from the Irish Medicines Board to manufacture culture-expanded stem cells for human use.
And it is one of less than half a dozen in Europe authorised for the process.
"Developing Galway's role as med-tech hub of global standing, the Centre for Cell Manufacturing Ireland captures NUI Galway's commitment to bring bold ideas to life," said NUI Galway president Dr Jim Browne.
"Innovation can bridge the gap between patient and provider and meet the needs of industry and the wider society in a balanced way."
Stem cells are best described as serving as the body's repair mechanism and in recent years science has isolated them from tissues such as bone marrow and fat to recreate them in laboratory settings.
See the rest here:
Ireland university lab in stem cells move
15 hours ago
A new method allows for large-scale generation of human embryonic stem cells of high clinical quality. It also allows for production of such cells without destroying any human embryos. The discovery is a big step forward for stem cell research and for the high hopes for replacing damaged cells and thereby curing serious illnesses such as diabetes and Parkinson's disease.
Currently human embryonic stem cells are made from surplus in vitro fertilized (IVF) embryos that are not used for the generation of pregnancies. The embryos do not survive the procedure. Therefore it has been illegal in the USA to to use this method for deriving embryonic stem cell lines. Sweden's legislation has been more permissive. It has been possible to generate embryonic stem cells from excess, early IVF embryos with the permission of the persons donating their eggs and sperm.
An international research team led by Karl Tryggvason, Professor of Medical Chemistry at Karolinska Institutet in Sweden and Professor at Duke-NUS Graduate Medical School in Singapore has, together with Professor Outi Hovatta at Karolinska Institutet, developed a method that makes it possible to use a single cell from an embryo of eight cells. This embryo can then be re-frozen and, theoretically, be placed in a woman's uterus. The method is already used in Pre-implantation Genetic Diagnosis (PGD) analyses, where a genetic test is carried out on a single cell of an IVF embryo in order to detect potential hereditary diseases. If mutations are are not detected, the embryo is inserted in the woman's uterus, where it can grow into a healthy child.
"We know that an embryo can survive the removal of a single cell. This makes a great ethical difference," says Karl Tryggvason.
The single stem cell is then cultivated on a bed of a human laminin protein known as LN-521 that is normally associated with pluripotent stem cells in the embryo. This allows the stem cell to duplicate and multiply without being contaminated. Previously the cultivation of stem cells has been done on proteins from animals or on human cells, which have contaminated the stem cells through uninhibited production of thousands of proteins.
"We can cultivate the stem cells in a chemically defined, clinical quality environment. This means that one can produce stem cells on a large scale, with the precision required for pharmaceutical production," says Karl Tryggvason.
Embryonic stem cells are pluripotent and can develop into any kind of cell. This means that they can become dopamine producing cells, insulin producing cells, heart muscle cells or eye cells, to name but a few of the hopes placed on cell therapy using stem cells.
"Using this technology the supply of human embryonic stem cells is no longer a problem. It will be possible to establish a bank where stem cells can be matched by tissue type, which is important for avoiding transplants being rejected," says Karl Tryggvason.
Explore further: Stem cells on the road to specialization
See the rest here:
New method increases supply of embryonic stem cells
SACRAMENTO, Calif. (AP) The state of California is preparing to invest up to $40 million in a new scientific field that backers say could revolutionize medicine and lead to personalized medical treatments.
The directors of the California Institute for Regenerative Medicine are meeting in Berkeley this Wednesday to create one or two research centers for stem-cell genomics, the Sacramento Bee (http://bit.ly/1mKZTRp) reported Sunday.
Scientists and biotech companies in the San Francisco Bay Area, San Diego and elsewhere are competing for the research money.
Researchers believe that genomics, the study of genes and their relationships, can lead to more effective therapies that are tailored to a patient's genetic makeup.
The new research centers for stem-cell genomics could help make California a leader in the fast-moving field.
"Right now, in a lot of ways, doctors are making educated guesses as to how to treat us patients more generally," said UC Davis stem cell researcher Paul Knoepfler. "By knowing our genomic information ... they could be making far more educated choices about treatments."
The move into genomics comes as the California Institute for Regenerative Medicine struggles to fulfill the promises of the 2004 ballot initiative campaign that created the $3 billion stem-cell agency.
So far, no new therapies have emerged from the state institute, which will run out of cash for new awards in less than three years and needs some high-profile success to raise more money.
Two years ago, the stem cell agency decided to move ahead with the plan to fund research into stem-cell genomics and began accepting applications for research money.
A group headed by Stanford University's Michael Snyder, director of its Center for Genomics and Personalized Medicine, is expected to receive a $33 million award, based on documents posted Friday on the agency's website.
Read the original post:
California to fund research in stem-cell genomics
Embryonic stem cells have been highly valued for their ability to turn into any type of cell in the body.
Stem cells can be manufactured for human use for the first time in Ireland, following Irish Medicines Board licensing of a new facility in Galway.
NUI Galways Centre for Cell Manufacturing Ireland aims to culture adult stem cells to tackle conditions such as arthritis, heart disease, diabetes and associated conditions.
The centre, which is one of less than half a dozen in Europe authorised for stem cell manufacture, has been developed by researchers at NUIGs regenerative medicine institute.
Stem cells serve as the bodys repair mechanism. They can be isolated from tissues such as bone marrow and fat, and cultured in laboratory settings.
More controversially, embryonic stem cells have been highly valued for their ability to turn into any type of cell in the body, but scientists can now use reprogrammed adult skin cells to create a stem cell that is very similar to embryonic versions.
The centre will be opened today by Minister of State for Research and Innovation Sen Sherlock, at a time when the Health Research Board and Science Foundation Ireland have approved funding there for clinical trials on using mesenchymal stem cells cells that can differentiate into a variety of types for treatment of critical limb ischemia, a condition associated with diabetes that can result in amputation.
The new centres director Prof Tim OBrien explained that the stem cells must be grown in the laboratory to generate sufficient quantities, following their isolation from the bone marrow of adult donors, and the facility will help Ireland to develop therapies for a broad range of clinical problems which do not have effective treatments today.
It will also allow us to translate discoveries from the basic stem cell research programme led by Prof Frank Barry at the Science Foundation Ireland-funded REMEDI to the clinic, and to be competitive for grant funding under the Horizon 2020 programme of the EU, he said.
Stem cell research in Ireland is in what scientists have described as a legislative lacuna, but this relates to use of embryonic stem cells and does not in any way inhibit the use of adult stem cells, Prof OBrien explained.
Read more here:
Ireland’s first stem cell manufacturing centre approved at NUI Galway